Depo-Provera是甲羟孕酮醋酸酯(DMPA)的长效注射剂。1960年起美国已作为商品药治疗子宫内膜异位症和先兆及习惯性流产,也有一些作为节育药的研究报告,此药主要通过对下丘脑-垂体系统的抑制作用而抑制排卵,发挥节育作用。本研究是印度妇女使用Depo-Provera作长效避孕针的临床报告。研究包括138名健康育龄妇女共907个周期,最长为24个周期,其平均年龄为25岁,其中74.5%为21～30岁,21.1%为16～20岁,4.4%为30岁以上妇女,大部分妇女均为生育1～2个孩子的妇女,其中46.6%为初产妇,3.3%为生育5胎以上。所有 Depo-Provera is a long-acting injection of medroxyprogesterone acetate (DMPA). Since 1960, the United States has treated endometriosis and threatened and habitual abortion as commercial drugs. There are also reports of studies on birth control that inhibit ovulation and inhibit ovulation mainly by inhibiting the hypothalamic-pituitary system, effect. This study is a clinical report of Indian women using Depo-Provera as long-acting contraception needle. The study included 138 healthy women of childbearing age for a total of 907 cycles up to a maximum of 24 cycles, with an average age of 25 years, 74.5% of whom were 21-30 years old, 21.1% of whom were 16-20 years old and 4.4% of whom were women over 30 years of age , Most of the women are women with one to two children, 46.6% of whom are primipara and 3.3% of whom have more than five births. all